Talk:Antivirals Taskforce (UK)
Appearance
This is the talk page for discussing improvements to the Antivirals Taskforce (UK) article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
This article is written in British English, which has its own spelling conventions (colour, travelled, centre, defence, artefact, analyse) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
Start a discussion about improving the Antivirals Taskforce (UK) page
Talk pages are where people discuss how to make content on Wikipedia the best that it can be. You can use this page to start a discussion with others about how to improve the "Antivirals Taskforce (UK)" page.
Categories:
- Stub-Class COVID-19 articles
- Low-importance COVID-19 articles
- WikiProject COVID-19 articles
- Stub-Class medicine articles
- Low-importance medicine articles
- All WikiProject Medicine pages
- Stub-Class United Kingdom articles
- Unknown-importance United Kingdom articles
- WikiProject United Kingdom articles
- Wikipedia articles that use British English